Microdosing might not work the way we think—but that doesn’t mean it doesn’t work. Here’s what science and the placebo effect reveal.

ncl.ac.uk There is evidence to suggest that rifampicin is an effective second line therapy for controlling pruritus in patients with chronic cholestatic liver disease. It is most widely used as an ...